SLC6A3 and Parkinson disease: DAT PET imaging studies have revealed that PD patients show a loss of about 60% [24] of the striatal dopamine transporters by the time motor symptoms emerged, although a more recent study claimed that the loss of striatal DAT activity is about 35–45% in early PD [10].